Back |
home / stock / amam / amam message board
Subject | By | Source | When |
---|---|---|---|
If and when we get it, do you | Go-Gold | investorshub | 12/13/2022 11:49:29 PM |
we are likely to get a fast track | Hercules1 | investorshub | 12/13/2022 11:44:07 PM |
Thanks, I will lock them up ;this is | Go-Gold | investorshub | 12/13/2022 11:39:47 PM |
Short Interest 4,364 shares - source: NYSE | surf1944 | investorshub | 12/13/2022 11:36:26 PM |
it is looking like we are going to | Hercules1 | investorshub | 12/13/2022 11:36:01 PM |
yep. it is best to lock up your shares. | Hercules1 | investorshub | 12/13/2022 11:33:58 PM |
The FDA usually requires a phase III clinical | surf1944 | investorshub | 12/13/2022 11:32:34 PM |
Question, does locking up our shares do anything? | Go-Gold | investorshub | 12/13/2022 11:26:46 PM |
Fast Track designation can be requested with nonclinical | Hercules1 | investorshub | 12/13/2022 10:54:58 PM |
This is not a short term play, most | surf1944 | investorshub | 12/13/2022 10:27:20 PM |
Oversold | Go-Gold | investorshub | 12/13/2022 10:01:02 PM |
It went up over 1000 percent for a | Hercules1 | investorshub | 12/13/2022 9:40:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) Company Name:
AMAM Stock Symbol:
NYSE Market:
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) Website:
Shandong Weigao Group Medical Polymer Co. Ltd. - Class H (SHWGF) is expected to report for Q4 2023 Country Garden Holdings Co., Ltd. ADR (CTRYY) is expected to report for Q4 2023 Mondi Plc ADR (New) (MONDY) is expected to report for Q4 2023 Telecom Italia S.p.A. ADR - Preference Share...
Ambrx Biopharma Inc. (AMAM) is expected to report $-0.41 for Q4 2023
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., (“Ambrx” or the “Company”) (NASDAQ: AMAM), today announced that its shareholders approved a proposal to adopt the merger agreement entered into between the Company and Johnson & Johnson at its Spe...